Headquartered in Stayner, ON Fiscal year ends December NASDAQ: CRON thecronosgroup.com
Cronos Group Inc. is a global cannabis company focused on scaling consumer goods products through research and development and innovation. The company operates across multiple geographies, with a strong presence in Canada, Israel, and growing international markets including Germany. Its brand portfolio includes Spinach® (Canada's #2 overall cannabis brand and #1 in vapes and edibles), PEACE NATURALS® (the #1 cannabis brand in Israel's medical market and expanding internationally), LIT™, and Lord Jones®. Cronos produces and sells cannabis flower, extracts (including vapes, edibles, and pre-rolls), and other cannabis products. The company maintains a substantial cash position and is backed by a strategic investment from Altria Group, Inc. Cronos operates cultivation and processing through its Peace Naturals Campus in Ontario and through Cronos GrowCo. The company is pursuing international expansion, with a pending acquisition of CanAdelaar B.V. in the Netherlands expected to close in the second half of 2026. Updated
Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday. The catalyst is growing speculation…
For years, North American cannabis investors have endured a brutal hangover. Cronos Group (NASDAQ:CRON), once a darling of the 2018-2019 marijuana mania, watched its share price collapse more than 95% from all-time…
Rich Duprey It wasn’t that long ago that cannabis stocks promised explosive growth after Canada legalized recreational marijuana in 2018 and U.S. states accelerated reforms. Investors poured billions into the sector, envisioning a booming…
From Hype to Hiccups in the Cannabis Craze Once hailed as the “next big thing,” cannabis stocks in 2018-2019 were the artificial intelligence stock darlings of their day, riding a wave of…
Dividend stocks don’t look hot at first, but if you sit back and let them compound for decades, these boring names can very well outperform the broader market. A tech stock can…
Dividend Kings are some of the most solid stocks to own in the market. The title means that the company has raised its dividends for the past 50 years straight. This is…
The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug.
Thursday's top analyst upgrades and downgrades included BioCryst Pharmaceutical, Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton Interactive, Snowflake, SoFi Technologies, XPO Logistics and Zoominfo Technologies.
President Biden on Thursday pardoned people who had been convicted of federal charges of simple possession of marijuana, sending pot stocks soaring. But strong headwinds remain for the industry.
Here is what analysts expect to hear when these five firms report quarterly results Monday and Tuesday.
Tuesday's additional top analyst upgrades and downgrades included Canopy Growth, ContextLogic, Cronos, Ecolab, Keurig Dr Pepper, LyondellBasell Industries, Procter & Gamble, Phillip Morris International, Sherwin-Williams and Upstart.
Thursday afternoon's top analyst upgrades and downgrades included Equifax, Corning, Iridium Communications, KB Home and Tesla.
Nearly every electric vehicle stock traded lower Thursday, as investors likely were pocketing some profits on the recent runup in these stocks.
Thursday afternoon's analyst upgrades and downgrades included Activision Blizzard, Boeing, Canopy Growth, GoPro, PayPal, Roblox, Visa and more.
Meme stocks, like Monday's broad markets, were trading higher, with more winners than losers and more new highs than new lows.
Cronos Group Inc. is a global cannabis company focused on scaling consumer goods products through research and development and innovation. The company operates across multiple geographies, with a strong presence in Canada, Israel, and growing international markets including Germany.
The Wall Street consensus 12-month price target for CRON is $2.47.
